A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Progression of Aortic Calcification in Stage 4-5 Chronic Kidney Disease Patients Transitioning to Dialysis and Transplantation




TekijätLankinen Roosa, Hakamäki Markus, Hellman Tapio, Koivuviita Niina S, Metsärinne Kaj, Järvisalo Mikko J

KustantajaKARGER

Julkaisuvuosi2022

JournalKidney and Blood Pressure Research

Tietokannassa oleva lehden nimiKIDNEY & BLOOD PRESSURE RESEARCH

Lehden akronyymiKIDNEY BLOOD PRESS R

Vuosikerta47

Numero1

Aloitussivu23

Lopetussivu30

Sivujen määrä8

ISSN1420-4096

eISSN1423-0143

DOIhttps://doi.org/10.1159/000518670

Verkko-osoitehttps://www.karger.com/Article/FullText/518670

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/68072290


Tiivistelmä

Background and Aims: Abdominal aortic calcification (AAC) is common in chronic kidney disease (CKD) patients and associated with increased mortality. Comparative data on the AAC score progression in CKD patients transitioning from conservative treatment to different modalities of renal replacement therapy (RRT) are lacking and were examined. Methods: 150 study patients underwent lateral lumbar radiograph to study AAC in the beginning of the study before commencing RRT (AAC1) and at 3 years of follow-up (AAC2). We examined the associations between repeated laboratory tests taken every 3 months, echocardiographic and clinical variables and AAC increment per year (ΔAAC), and the association between ΔAAC and outcomes during follow-up. Results: At the time of AAC2 measurement, 39 patients were on hemodialysis, 39 on peritoneal dialysis, 39 had a transplant, and 33 were on conservative treatment. Median AAC1 was 4.8 (0.5-9.0) and median AAC2 8.0 (1.5-12.0) (p < 0.0001). ΔAAC was similar across the treatment groups (p = 0.19). ΔAAC was independently associated with mean left ventricular mass index (LVMI) (log LVMI: β = 0.97, p = 0.02) and mean phosphorus through follow-up (log phosphorus: β = 1.19, p = 0.02) in the multivariable model. Time to transplantation was associated with Delta AAC in transplant recipients (per month on the waiting list: β = 0.04, p = 0.001). Delta AAC was associated with mortality (HR 1.427, 95% confidence interval 1.044-1.950, p = 0.03). Conclusion: AAC progresses rapidly in patients with CKD, and ΔAAC is similar across the CKD treatment groups including transplant recipients. The increment rate is associated with mortality and in transplant recipients with the time on the transplant waiting list.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:43